Abstract 4633: Theranostic evaluation of 68Ga-PMSA, 177Lu PSMA therapy, and biomarker guided immunotherapy and DDR inhibitor combinations in LNCaP prostate cancer xenografts
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Medicines Discovery Catapult
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148651817
Cites:
Cited by:
Related to:
